This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2004 May 13;350(20):2089-90.

doi: 10.1056/NEJMe048030.

Homocysteine and osteoporotic fractures--culprit or bystander?

Lawrence G Raisz

PMID: 15141048
DOI: 10.1056/NEJMe048030

Editorial

Homocysteine and osteoporotic fractures--culprit or bystander?

Lawrence G Raisz. N Engl J Med. 2004.

. 2004 May 13;350(20):2089-90.

doi: 10.1056/NEJMe048030.

Author

Lawrence G Raisz

PMID: 15141048
DOI: 10.1056/NEJMe048030

No abstract available

PubMed Disclaimer

Comment in

Homocysteine as a predictive factor for hip fracture in older persons.
Bursztyn M. Bursztyn M. N Engl J Med. 2004 Sep 2;351(10):1027-30; author reply 1027-30. N Engl J Med. 2004. PMID: 15352274 No abstract available.
Homocysteine as a predictive factor for hip fracture in older persons.
Ellenberg SS, Orloff DG, Temple RJ. Ellenberg SS, et al. N Engl J Med. 2004 Sep 2;351(10):1027-30; author reply 1027-30. N Engl J Med. 2004. PMID: 15352276 No abstract available.

Comment on

Homocysteine levels and the risk of osteoporotic fracture.
van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A, Witteman JC, van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG. van Meurs JB, et al. N Engl J Med. 2004 May 13;350(20):2033-41. doi: 10.1056/NEJMoa032546. N Engl J Med. 2004. PMID: 15141041
Homocysteine as a predictive factor for hip fracture in older persons.
McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP. McLean RR, et al. N Engl J Med. 2004 May 13;350(20):2042-9. doi: 10.1056/NEJMoa032739. N Engl J Med. 2004. PMID: 15141042

Similar articles

Homocysteine levels and the risk of osteoporotic fracture.
van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A, Witteman JC, van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG. van Meurs JB, et al. N Engl J Med. 2004 May 13;350(20):2033-41. doi: 10.1056/NEJMoa032546. N Engl J Med. 2004. PMID: 15141041
Homocysteine as a predictive factor for hip fracture in older persons.
Auer J, Lamm G, Eber B. Auer J, et al. N Engl J Med. 2004 Sep 2;351(10):1027-30; author reply 1027-30. doi: 10.1056/NEJM200409023511017. N Engl J Med. 2004. PMID: 15342813 No abstract available.
Homocysteine as a predictive factor for hip fracture in older persons.
Pérez-Castrillón JL, Arranz-Peña ML, Luis DD. Pérez-Castrillón JL, et al. N Engl J Med. 2004 Sep 2;351(10):1027-30; author reply 1027-30. N Engl J Med. 2004. PMID: 15352275 No abstract available.
Homocysteine and osteoporotic fracture risk: a potential role for B vitamins.
Cashman KD. Cashman KD. Nutr Rev. 2005 Jan;63(1):29-36. doi: 10.1111/j.1753-4887.2005.tb00108.x. Nutr Rev. 2005. PMID: 15730233 Review.
Fighting the fracture cascade: evaluation and management of osteoporotic fractures.
Sack F. Sack F. Postgrad Med. 2008 Nov;120(4):51-7. doi: 10.3810/pgm.2008.11.1938. Postgrad Med. 2008. PMID: 19020365 Review.

See all similar articles

Cited by

Inferring causal effects of homocysteine and B-vitamin concentrations on bone mineral density and fractures: Mendelian randomization analyses.
Fu L, Wang Y, Hu YQ. Fu L, et al. Front Endocrinol (Lausanne). 2022 Nov 28;13:1037546. doi: 10.3389/fendo.2022.1037546. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36518252 Free PMC article.
Genetic variants modify the associations of concentrations of methylmalonic acid, vitamin B-12, vitamin B-6, and folate with bone mineral density.
Liu CT, Karasik D, Xu H, Zhou Y, Broe K, Cupples LA, Cpgm de Groot L, Ham A, Hannan MT, Hsu YH, Jacques P, McLean RR, Paul L, Selhub J, Trajanoska K, van der Velde N, van Schoor N, Kiel DP. Liu CT, et al. Am J Clin Nutr. 2021 Aug 2;114(2):578-587. doi: 10.1093/ajcn/nqab093. Am J Clin Nutr. 2021. PMID: 33964857 Free PMC article.
Homocysteine as a Pathological Biomarker for Bone Disease.
Behera J, Bala J, Nuru M, Tyagi SC, Tyagi N. Behera J, et al. J Cell Physiol. 2017 Oct;232(10):2704-2709. doi: 10.1002/jcp.25693. Epub 2017 Apr 12. J Cell Physiol. 2017. PMID: 27859269 Free PMC article. Review.
Effect of B vitamin (folate, B6, and B12) supplementation on osteoporotic fracture and bone turnover markers: a meta-analysis.
Ruan J, Gong X, Kong J, Wang H, Zheng X, Chen T. Ruan J, et al. Med Sci Monit. 2015 Mar 24;21:875-81. doi: 10.12659/MSM.893310. Med Sci Monit. 2015. PMID: 25805360 Free PMC article.
The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial.
Gommans J, Yi Q, Eikelboom JW, Hankey GJ, Chen C, Rodgers H; VITATOPS trial study group. Gommans J, et al. BMC Geriatr. 2013 Sep 3;13:88. doi: 10.1186/1471-2318-13-88. BMC Geriatr. 2013. PMID: 24004645 Free PMC article. Clinical Trial.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information